Medicare Enrolled

Dr. Mazen Elkurd, D.O.

Neurology · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
3417 GASTON AVE STE 935, Dallas, TX 75246
4698007680
In practice since 2015 (11 years)
NPI: 1891180311 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Elkurd from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Elkurd? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Elkurd

Dr. Mazen Elkurd is a neurology in Dallas, TX, with 11 years in practice. Based on federal Medicare data, Dr. Elkurd performed 20,149 Medicare services across 739 unique beneficiaries.

Between the years covered by Open Payments, Dr. Elkurd received a total of $47,210 from 53 pharmaceutical and/or device companies across 528 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Elkurd is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice▲ Top 4% volume in TX$ $47,210 industry payments

Medicare Practice Summary

Medicare Utilization ↗
20,149
Medicare services
Top 4% in TX for neurology
739
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,832 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit8,780$5$19
Botox injection (Xeomin), per unit7,250$4$16
Injection, abobotulinumtoxina, 5 units3,120$7$26
Office visit, established patient (30-39 min)307$92$238
New patient office visit, complex (60-74 min)125$146$409
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle81$61$294
Office visit, established patient, complex (40-54 min)80$134$335
Office visit, established patient (20-29 min)77$64$168
Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box58$115$796
Injection of chemical for paralysis of nerve muscles on side of face56$124$778
Punch biopsy, each additional skin growth48$45$246
Injection of chemical for paralysis of nerve muscles on trunk, 1-5 muscles42$82$688
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or32$25$84
Blood draw (venipuncture)30$8$17
Punch biopsy, first skin growth24$88$527
New patient office visit (45-59 min)17$99$310
Drug injection, under skin or into muscle11$11$65
Office visit, established patient (10-19 min)11$41$105
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$47,210
Total received (2018-2024)
Avg $7,868/year across 6 years
Top 10% in TX for neurology
53
Companies
528
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$15,000 (31.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,680 (29.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,051 (25.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,479 (13.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,088
2023
$18,889
2022
$3,847
2021
$445
2019
$17,817
2018
$125

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$15,468
Boston Scientific Corporation
$15,341
Kyowa Kirin, Inc.
$3,574
ACADIA Pharmaceuticals Inc
$1,994
MDD US Operations, LLC
$1,446
UCB, Inc.
$1,071
Medtronic USA, Inc.
$1,049
ABBVIE INC.
$947
Lundbeck LLC
$851
Neurocrine Biosciences, Inc.
$807
Amneal Pharmaceuticals LLC
$433
Merz Pharmaceuticals, LLC
$374
Teva Pharmaceuticals USA, Inc.
$332
Lilly USA, LLC
$303
ARGENX US, INC.
$213
Biogen, Inc.
$197
BOSTON SCIENTIFIC CORPORATION
$191
Grifols USA, LLC
$182
Ipsen Biopharmaceuticals, Inc
$181
Alexion Pharmaceuticals, Inc.
$170
PFIZER INC.
$168
SK Life Science, Inc.
$167
Medtronic, Inc.
$165
IDORSIA PHARMACEUTICALS US INC
$127
AbbVie, Inc.
$125
Acorda Therapeutics, Inc
$123
Neurelis, Inc.
$119
Harmony Biosciences LLC
$117
MITSUBISHI TANABE PHARMA AMERICA, INC.
$75
Averitas Pharma Inc.
$67
GE HealthCare
$66
Takeda Pharmaceuticals U.S.A., Inc.
$60
Jazz Pharmaceuticals Inc.
$59
Biohaven Pharmaceutical Holding Company Ltd.
$58
JAZZ PHARMACEUTICALS INC.
$55
Amgen Inc.
$55
Alnylam Pharmaceuticals Inc.
$49
Avion Pharmaceuticals
$49
Octapharma USA, Inc.
$41
Merz North America, Inc.
$40
Sunovion Pharmaceuticals Inc.
$39
Eisai Inc.
$38
Sumitomo Pharma America, Inc.
$27
AstraZeneca Pharmaceuticals LP
$23
Azurity Pharmaceuticals, Inc.
$23
Avanir Pharmaceuticals, Inc.
$23
CATALYST PHARMACEUTICALS, INC.
$22
SCILEX PHARMACEUTICALS INC.
$21
Harmony Biosciences Llc
$20
Catalyst Pharmaceuticals, Inc.
$19
Corium, LLC
$17
HARMONY BIOSCIENCES LLC
$14
IMPEL PHARMACEUTICALS INC.
$14
Top 3 companies account for 72.8% of total payments
Associated products mentioned in payments ›
ACTIVA · ACTIVA PC · AMYVID · APOKYN · APTIOM · AUSTEDO · Adlarity · Aimovig · Austedo XR · BOTOX · Briviact · CREXONT · Cimzia · DAYBUE · DUOPA · DYSPORT · Deep Brain Stimulation · Dhivy · Duopa · Dysport · EMGALITY · EPIDIOLEX · FIRDAPSE · Fintepla · GAMMAGARD · GENERAL DBS · Gamunex-C · General - DBS · Gocovri · HYQVIA · Horizant · INBRIJA · INFINITY · INGREZZA · Leqembi · MYOBLOC · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · Ongentys · PANZYGA · PERCEPT PC BRAINSENSE · PROCLAIM · QULIPTA · QUTENZA · QUVIVIQ · RADICAVA · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · Skyclarys · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · WAKIX · Wakix · XADAGO · XEOMIN · Xeomin · ZAVZPRET · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (32%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 10% for neurology in TX.

Equivalent to $234 per 100 Medicare services performed
Looking for a neurology in Dallas?
Compare neurologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
230
Per 100K population
8.8
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Elkurd is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), and high industry engagement (mixed engagement, top 10%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Elkurd experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Elkurd performed 8,780 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Elkurd receive payments from pharmaceutical companies?
Yes. Dr. Elkurd received a total of $47,210 from 53 companies across 528 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Elkurd's costs compare to other neurologys in Dallas?
Dr. Elkurd's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Elkurd) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →